 |
Genexol-PM wins Korea New Drug Award |
 |
GENEXOL-PM™ (next generation anti-cancer agent using Paclitaxel, injection)
marketed in Korea |
 |
Daedeok pharmaceutical plant extended |
 |
Genexol-PM wins Health industry & technology award |
 |
Medical management information system built |
 |
Nicostop troche approved |
 |
Nexatin injection(oxaliplatin) approved |
 |
"Business Agreement" reached with Akina, Inc. of the U.S. on Cetirizine FDT |
 |
"R&D Agreement" reached with Hyundai Pharmaceutical of Korea on Cetirizine
Hydrochloride FDT |
 |
Phase II clinical trials of Genexol PM on breast cancer II initiated at Asan Medical Center, etc. |
 |
Suture Monosorb-Pro approved |
 |
Genexol Injection certified as effective in gastric cancer treatment |
 |
"R&D Agreement" reached with Akina, Inc. of the U.S. |
 |
Phase II clinical trials of Genexol PM on non-small cell lung cancer initiated
at Seoul National University Hospital, etc. |
 |
Phase II clinical trials of Genexol PM on breast cancer I initiated
at Seoul National University Hospital, etc. |
 |
Genexol Injection certified as effective in ovarian cancer treatment |
 |
"R&D Agreement" reached with Lavipharm of Greece and technical transfer of
Nicostop completed |
 |
Genexol Injection certified as effective in lung cancer treatment |
 |
Pharmaceutical research corporation established in Utah Samyang Research Corporation
(SRC) |
 |
Genexol-PM receives U.S. IND approval |
 |
100 mg Genexol-PM Injection approved |
 |
"Business Agreement" reached with Akina, Inc. of the U.S. |
 |
30 mg Genexol-PM Injection approved |
 |
Genexol Injection certified as effective in breast cancer treatment |
 |
"R&D Agreement" reached with Transform Pharmaceuticals, Inc. of the U.S. |
 |
"Business Agreement" reached with Transform Pharmaceuticals, Inc. of the U.S. |
 |
Surgisorb and BioMesh acquire CE mark |
 |
Three R&D Agreementsreached with MacroMed, Inc. of the U.S. on hGH, pGH,
Tramadol, and G-CSF |
 |
|
 |
 |
Medical devices acquire ISO 9001 & EN 46001 certification |
 |
BioMesh approved |
 |
KGMP certification for medical device received |
 |
Genexol Injection approved and released (Jun 1, 2001) |
 |
Reumastop Plaster approved |
 |
Surgisorb, an absorbable suture product, approved and released (Dec 1, 1998) |
 |
Trisorb wins Jang Young Shil Award |
 |
Nicostop patches approved |
 |
KGMP certification for pharmaceuticals received |
 |
"Business Agreement" reached with AmCyte, Inc. of the U.S. |
 |
"Business Agreement" reached with VivoRx Pharmaceutical, Inc. of the U.S. |
 |
"R&D Agreement" reached with MacroMed, Inc. of the U.S. and Gene Delivery System
developed |
 |
"R&D Agreement" reached with TheraTech, Inc. of the U.S. on Combitran-MTX |
 |
"R&D Agreement" reached with TheraTech, Inc. of the U.S. on Estran-MTX |
 |
Medical suture products win patented technology award |
 |
"R&D Agreement" reached with TheraTech, Inc. of the U.S. on Androderm-LRS
and Angiderm-MTX patches |
 |
"Business Agreement" reached with MacroMed, Inc. of the U.S. |
 |
Medical suture products granted the Korea Good Technology mark |
 |
Pharmaceutical Research Center established |
|
